Intellia Therapeutics, Inc. (NTLA) - Comprehensive Stock Analysis & Investment Research
Deep dive into Intellia Therapeutics, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Understanding Company Overview
What this section covers: Essential business information about Intellia Therapeutics, Inc., including sector classification, industry positioning, and organizational structure.
How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.
For Intellia Therapeutics, Inc.: Intellia Therapeutics, Inc. operates in the Life Sciences sector, making it an emerging small-cap investment.
Intellia Therapeutics, Inc. (Stock Symbol: NTLA) is a leading company in the Life Sciences sector , specifically operating within the In Vitro & In Vivo Diagnostic Substances industry.
The organization employs approximately 652 professionals worldwide .
The company has established itself as an emerging investment opportunity with substantial growth potential.
Understanding Financial Performance
What these metrics mean: Key financial indicators showing Intellia Therapeutics, Inc.'s revenue scale, profitability, market value, and shareholder returns.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Intellia Therapeutics, Inc.: With $34M in annual revenue and -1537.8% net margin, the company demonstrates developing profitability.
Annual Revenue: $34 million generating a -1537.8% net profit margin .
Market Capitalization: $1225 million - Classified as a small-cap investment offering high growth potential.
Return on Equity (ROE): -49.2% - Below-average shareholder return efficiency, indicating areas for operational improvement.
Understanding AI Stock Predictions
What these predictions mean: AI-powered forecasts for Intellia Therapeutics, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.
How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.
For Intellia Therapeutics, Inc.: Unlock premium access to view detailed AI predictions and price targets.
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Intellia Therapeutics, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Understanding Market Position
What this analysis covers: Intellia Therapeutics, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.
How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.
For Intellia Therapeutics, Inc.: Market positioning analysis based on available financial and operational metrics.
Intellia Therapeutics, Inc. strategically competes in the highly dynamic In Vitro & In Vivo Diagnostic Substances marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .
The company maintains a healthy 30.6% gross margin, indicating strong pricing power and operational efficiency.